TABLE 1.
Case mix comparison for the training and prospective testing patient cohorts
| Tumour type | Demographics | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Training set | Test set | ||||||||||
| N | M/F | Age/y | N | M/F | Age/y | ||||||
| Range | Mean | SD | Range | Mean | SD | ||||||
| Before QC | Pilocytic astrocytoma | 13 | 7/6 | 3.3–15.5 | 9.0 | 3.9 | 21 | 9/12 | 2.1–14.6 | 8.9 | 4.1 |
| Ependymoma | 5 | 3/2 | 1.0–3.3 | 1.9 | 1.1 | 4 | 3/1 | 2.4–16.3 | 6.0 | 6.8 | |
| Medulloblastoma | 18 | 12/6 | 2.4–15.1 | 7.0 | 3.9 | 14 | 12/2 | 2.1–13.8 | 7.9 | 3.8 | |
| All | 36 | 22/14 | 1.0–15.5 | 7.2 | 4.3 | 39 | 24/15 | 2.1–16.3 | 8.2 | 4.3 | |
| After QC | Pilocytic astrocytoma | 12 | 6/6 | 3.3–13.2 | 8.4 | 3.3 | 16 | 8/8 | 2.1–13.7 | 9.3 | 4 |
| Ependymoma | 4 | 2/2 | 1.0–3.3 | 2.0 | 1.1 | 3 | 2/1 | 2.4–2.8 | 2.6 | 0.2 | |
| Medulloblastoma | 18 | 12/6 | 2.4–15.1 | 7.0 | 3.9 | 14 | 12/2 | 2.1–13.8 | 7.9 | 33.8 | |
| All | 34 | 20/14 | 1.0–15.1 | 7.1 | 4.1 | 33 | 22/11 | 2.1–13.8 | 8.1 | 4.1 | |
Abbreviation: QC, quality control.